While I sympathise with your sentiments, AceHomer, the situation for infant formula regulation and supply in the United States is complex and would not allow for easy dumping of product. For a start there are import tariffs ranging up to 17.5%. Second, there is something called the Federal "Women, Infants, and Children (WIC) program". This program has restrictive rules which limit new mothers to buying formula from sole-source contractors in the various states, which manage the WIC. In addition, there is a fair bit of skullduggery at the State level, so that suppliers create state-sanctioned monopolies by offering kick-backs to State governments (and maybe officials?). Finally, paediatricians in the US are not above recommending particular brands of infant formula to new mothers, especially when those brands might offer generous "educational incentives" to the paediatrician. As a result, WIC makes up about half of the U.S. formula market, and Abbott and Mead Johnson have program contracts covering 87% of infants. I'm in the health industry, so I know how it works. Like I said, not so easy!
- Forums
- ASX - By Stock
- BUB
- BUB - US Exposure & The Current Baby Formula Shortage
BUB - US Exposure & The Current Baby Formula Shortage, page-39
-
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUB (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $104.9M |
Open | High | Low | Value | Volume |
12.0¢ | 12.0¢ | 11.5¢ | $67.38K | 573.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
75 | 3600657 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.0¢ | 1154196 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
75 | 3600657 | 0.115 |
67 | 3197267 | 0.110 |
24 | 1386270 | 0.105 |
42 | 1312046 | 0.100 |
3 | 110870 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.120 | 1104196 | 20 |
0.125 | 1370600 | 23 |
0.130 | 1851240 | 37 |
0.135 | 1277545 | 27 |
0.140 | 2021195 | 23 |
Last trade - 13.49pm 13/11/2024 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online